Peter Shintaku

2.3k total citations · 1 hit paper
30 papers, 1.9k citations indexed

About

Peter Shintaku is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Peter Shintaku has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Peter Shintaku's work include Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (3 papers). Peter Shintaku is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (3 papers). Peter Shintaku collaborates with scholars based in United States, Denmark and Canada. Peter Shintaku's co-authors include Jonathan Said, Elena Elstner, H. Phillip Koeffler, David Heber, Elizabeth A. Williamson, Hiroya Asou, Carsten Müller‐Tidow, Dorothy Park, Kozo Koshizuka and Neda A. Moatamed and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Peter Shintaku

30 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1998 719 citations Elena Elstner, Peter Shintaku et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Shintaku United States	19	1.0k	630	553	273	253	30	1.9k
Karl‐Heinz Thierauch Germany	19	1.0k 1.0×	908 1.4×	409 0.7×	146 0.5×	265 1.0×	33	2.5k
Douglas Armellino United States	15	1.3k 1.3×	738 1.2×	401 0.7×	247 0.9×	99 0.4×	18	2.3k
Thomas Bogenrieder Germany	25	1.2k 1.2×	1.2k 1.8×	536 1.0×	371 1.4×	191 0.8×	63	2.6k
Mohit Trikha United States	29	1.2k 1.2×	930 1.5×	384 0.7×	402 1.5×	81 0.3×	55	2.5k
Todd G. Kroll United States	19	1.5k 1.5×	715 1.1×	573 1.0×	153 0.6×	240 0.9×	23	2.8k
Randall Schreck United States	9	1.5k 1.5×	686 1.1×	469 0.8×	167 0.6×	117 0.5×	13	2.3k
Angela Garofalo Italy	23	985 1.0×	807 1.3×	687 1.2×	345 1.3×	125 0.5×	35	2.0k
Kazuhiro Yoshida Japan	27	1.1k 1.1×	788 1.3×	515 0.9×	157 0.6×	325 1.3×	49	2.0k
Yoshinobu Toda Japan	26	1.2k 1.1×	496 0.8×	440 0.8×	160 0.6×	293 1.2×	50	2.0k
Lars Damstrup Denmark	19	902 0.9×	910 1.4×	226 0.4×	122 0.4×	134 0.5×	43	1.9k

Countries citing papers authored by Peter Shintaku

Since Specialization

Citations

This map shows the geographic impact of Peter Shintaku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Shintaku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Shintaku more than expected).

Fields of papers citing papers by Peter Shintaku

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Shintaku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Shintaku. The network helps show where Peter Shintaku may publish in the future.

Co-authorship network of co-authors of Peter Shintaku

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Shintaku. A scholar is included among the top collaborators of Peter Shintaku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Shintaku. Peter Shintaku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lisberg, Aaron, Siwen Hu‐Lieskovan, Tristan Grogan, et al.. (2018). P2.09-05 Evaluation of PD-L1-Stained Tumor Cells via the 22C3 and SP-142 Antibodies in Cohort of Patients Treated on KEYNOTE-001. Journal of Thoracic Oncology. 13(10). S761–S761. 2 indexed citations

Shintaku, Peter, et al.. (2018). Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas. PLoS ONE. 13(4). e0195958–e0195958. 45 indexed citations

Shintaku, Peter, et al.. (2017). Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas. Diagnostic Pathology. 12(1). 45–45. 99 indexed citations

Khanlou, Négar, Peter Shintaku, Jennifer Y. Yi, & Neda A. Moatamed. (2015). Evaluation of PAX8 Expression in Brain Tissue and Related Neoplasms. Applied immunohistochemistry & molecular morphology. 24(3). 207–209. 5 indexed citations

Kansal, Rina, Xinmin Li, Joseph Shen, et al.. (2015). An infant with MLH3 variants, FOXG1‐duplication and multiple, benign cranial and spinal tumors: A clinical exome sequencing study. Genes Chromosomes and Cancer. 55(2). 131–142. 4 indexed citations

Su, Albert, Sarah Dry, Scott W. Binder, et al.. (2013). Malignant Melanoma With Neural Differentiation. American Journal of Dermatopathology. 36(1). e5–e9. 15 indexed citations

Yang, Huimin, Chi Lai, David W. Gjertson, et al.. (2008). Has the 2004 revision of the International Society of Heart and Lung Transplantation grading system improved the reproducibility of the diagnosis and grading of cardiac transplant rejection?. Cardiovascular Pathology. 18(4). 198–204. 39 indexed citations

Fishbein, Michael C., et al.. (2007). Mucinous Adenocarcinomas of the Thymus. The American Journal of Surgical Pathology. 31(9). 1330–1336. 29 indexed citations

Tso, Cho-Lea, Peter Shintaku, James Chen, et al.. (2006). Primary Glioblastomas Express Mesenchymal Stem-Like Properties. Molecular Cancer Research. 4(9). 607–619. 184 indexed citations

10.

Ko, Christine J., Peter Shintaku, & Scott W. Binder. (2005). Comparison of benign keratoses using p53, bcl‐1, and bcl‐2. Journal of Cutaneous Pathology. 32(5). 356–359. 14 indexed citations

11.

Chantranuwat, Chavit, Jian-Hua Qiao, Jon Kobashigawa, et al.. (2004). Immunoperoxidase Staining for C4d on Paraffin-embedded Tissue in Cardiac Allograft Endomyocardial Biopsies. Applied immunohistochemistry & molecular morphology. 166–171. 61 indexed citations

12.

Zisman, Amnon, Allan J. Pantuck, Matthew Bui, et al.. (2003). LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.. PubMed. 63(16). 4952–9. 13 indexed citations

13.

Goodarzi, Mark O., David W. Dawson, Xian Li, et al.. (2003). Virilization in Bilateral Macronodular Adrenal Hyperplasia Controlled by Luteinizing Hormone. The Journal of Clinical Endocrinology & Metabolism. 88(1). 73–77. 63 indexed citations

14.

Memarzadeh, Sanaz, Katherine R. Kozak, Sathima Natarajan, et al.. (2002). Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. Proceedings of the National Academy of Sciences. 99(16). 10647–10652. 66 indexed citations

15.

Shintaku, Peter, et al.. (2001). Her-2/neu Gene Amplification in Low to Moderately Expressing Breast Cancers: Possible Role of Chromosome 17/Her-2/neu Polysomy. The Breast Journal. 7(5). 337–344. 64 indexed citations

16.

Tso, C L, Amnon Zisman, José Miguel Hernández‐Andreu, et al.. (2001). Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.. PubMed. 61(21). 7925–33. 56 indexed citations

17.

Butterfield, Lisa H., Charles M. Vollmer, Fritz C. Eilber, et al.. (2000). Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.. PubMed. 60(22). 6457–64. 25 indexed citations

18.

Elstner, Elena, Moray J. Campbell, Reinhold Munker, et al.. (1999). Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. The Prostate. 40(3). 141–149. 42 indexed citations

19.

Lones, Mark A., Geraldine S. Pinkus, Peter Shintaku, & Jonathan Said. (1994). bcl-2 Oncogene Protein Is Preferentially Expressed in Reed-Sternberg Cells in Hodgkin’s Disease of the Nodular Sclerosis Subtype. American Journal of Clinical Pathology. 102(4). 464–467. 9 indexed citations

20.

Shintaku, Peter, et al.. (1988). Human chorionic gonadotropin expression in lung, breast, and renal carcinomas.. PubMed. 112(3). 282–5. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact